4//SEC Filing
Beeler Brian K 4
Accession 0001209191-21-051912
CIK 0001492426other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:01 PM ET
Size
9.2 KB
Accession
0001209191-21-051912
Insider Transaction Report
Form 4
Beeler Brian K
EVP, General Counsel
Transactions
- Sale
Ordinary Shares
2021-08-16$106.00/sh−74,898$7,939,188→ 90,918 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-16−65,857→ 0 totalExercise: $22.14Exp: 2025-03-22→ Ordinary Shares (65,857 underlying) - Exercise/Conversion
Ordinary Shares
2021-08-16$22.14/sh+65,857$1,458,074→ 165,816 total
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.6312 to $106.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001641580
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:01 PM ET
- Size
- 9.2 KB